BEAM
Price
$17.03
Change
-$1.45 (-7.85%)
Updated
Apr 3, 11:05 AM (EDT)
Capitalization
1.85B
40 days until earnings call
CRSP
Price
$34.19
Change
+$1.05 (+3.17%)
Updated
Apr 2 closing price
Capitalization
2.93B
39 days until earnings call
Ad is loading...

BEAM vs CRSP

Header iconBEAM vs CRSP Comparison
Open Charts BEAM vs CRSPBanner chart's image
Beam Therapeutics
Price$17.03
Change-$1.45 (-7.85%)
Volume$3.18K
Capitalization1.85B
CRISPR Therapeutics AG
Price$34.19
Change+$1.05 (+3.17%)
Volume$1.76M
Capitalization2.93B
BEAM vs CRSP Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CRSP commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CRSP is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BEAM: $18.48 vs. CRSP: $34.19)
Brand notoriety: BEAM and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 108% vs. CRSP: 79%
Market capitalization -- BEAM: $1.85B vs. CRSP: $2.93B
BEAM [@Biotechnology] is valued at $1.85B. CRSP’s [@Biotechnology] market capitalization is $2.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • CRSP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both BEAM and CRSP are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -15.65% price change this week, while CRSP (@Biotechnology) price change was -12.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.20%. For the same industry, the average monthly price growth was -10.26%, and the average quarterly price growth was -14.39%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

CRSP is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-8.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($2.93B) has a higher market cap than BEAM($1.85B). CRSP YTD gains are higher at: -13.135 vs. BEAM (-25.484). BEAM has higher annual earnings (EBITDA): -383.98M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. BEAM (851M). BEAM has less debt than CRSP: BEAM (161M) vs CRSP (224M). BEAM has higher revenues than CRSP: BEAM (63.5M) vs CRSP (35M).
BEAMCRSPBEAM / CRSP
Capitalization1.85B2.93B63%
EBITDA-383.98M-447.31M86%
Gain YTD-25.484-13.135194%
P/E RatioN/AN/A-
Revenue63.5M35M181%
Total Cash851M1.9B45%
Total Debt161M224M72%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCRSP
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAIFX9.160.04
+0.44%
MoA International Fund
HDQVX16.260.01
+0.06%
Janus Henderson Responsible Intl DivS
RYFAX83.56N/A
N/A
Rydex Financial Services H
BCSCX8.55N/A
N/A
BlackRock Commodity Strategies Inv C
MEMRX30.33-0.03
-0.10%
MFS Emerging Markets Equity R1

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+3.17%
BEAM - CRSP
72%
Closely correlated
+4.79%
RXRX - CRSP
68%
Closely correlated
+3.83%
NTLA - CRSP
64%
Loosely correlated
+9.69%
PRME - CRSP
62%
Loosely correlated
+0.28%
ALLO - CRSP
59%
Loosely correlated
+5.11%
More